Open original FDA record ↗Recall record
- FDA identifier
- Z-1362-2019
- Company in FDA record
- Abbott Laboratories
- FDA record creation date
- May 16, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Devices were delivered without the required dry ice.
Source facts
- Action
- On about 04/04/2019, Abbott notified customers in Latvia of the recall. Instructions included to examine inventory for any affected devices on hand, review the letter with your Medical Director or Laboratory Management and follow your laboratory protocol regarding the need for reviewing previously reported patient results, complete and return the Customer Reply form, and notify customers if the affected devices have been forwarded to other laboratories and provide them a copy of the notification letter. If replacement material is available, customers were instructed to discontinue the use of affected devices and destroy any remaining inventory according to your laboratory procedures. If replacement material is not available, immediately order replacement material. Abbott instructed customers that they may continue to use the impacted material as long as controls are within range. Destroy impacted material once replacement material is available.
- Initiated
- 2019-04-09
- Root cause
- Under Investigation by firm
- Terminated
- 2019-12-20
- Distribution
- Distribution to Latvia.
- Recall number
- Z-1362-2019
- Recall status
- Terminated
- CDRH record ID
- 171959
- FDA record created
- 2019-05-16
- Recall event number
- 82590